BillionToOne, Inc.BLLN
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NASDAQ · United States · billiontoone.com
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
Key ratios
FCF / Sales
5.2%2025
2024
-30.7%2023
-83.4%
Net margin
8.4%TTM
2025
1.0%2024
-27.2%2023
-115.3%
ROA
5.2%TTM
2025
2.1%2024
-11.9%
ROE
10.7%TTM
2025
2.3%2024
-41.9%
Revenue growth
90.1%TTM
2025
100.0%2024
112.7%
Track BLLN in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer